LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 2766

Search options

  1. Book ; Online ; E-Book: Cell-derived Matrices / Part B /

    Caballero, David / Kundu, Subhas C. / Reis, Rui L.

    (Methods in cell biology ; Volume 157)

    2020  

    Author's details edited by David Caballero, Subhas C. Kundu, Rui L. Reis
    Series title Methods in cell biology ; Volume 157
    Keywords Extracellular matrix
    Subject code 572.6
    Language English
    Size 1 online resource (xv, 247 pages) :, illustrations (color, black and white)
    Publisher Academic Press
    Publishing place Cambridge, MA
    Document type Book ; Online ; E-Book
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    ISBN 0-12-820174-6 ; 978-0-12-820174-9
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  2. Article ; Online: Vitamin B

    Mosca, Pauline / Robert, Aurélie / Alberto, Jean-Marc / Meyer, Marie / Kundu, Urbi / Hergalant, Sébastien / Umoret, Rémy / Coelho, David / Guéant, Jean-Louis / Leheup, Bruno / Dreumont, Natacha

    Molecular nutrition & food research

    2021  Volume 65, Issue 17, Page(s) e2100206

    Abstract: Introduction: Vitamin B: Methods and results: This study observes two cellular models deficient ... in vitamin B: Conclusion: Our data show that m6A methylation in mRNA could be one of the contributing ... mechanisms that underlie the neurological manifestations produced by vitamin B ...

    Abstract Introduction: Vitamin B
    Methods and results: This study observes two cellular models deficient in vitamin B
    Conclusion: Our data show that m6A methylation in mRNA could be one of the contributing mechanisms that underlie the neurological manifestations produced by vitamin B
    MeSH term(s) Adenosine/analogs & derivatives ; Adenosine/genetics ; Animals ; Fibroblasts ; Gene Expression Regulation ; Methylation ; Mice, Knockout ; Protein Kinase C-alpha/genetics ; Protein Kinase C-alpha/metabolism ; RNA, Messenger/metabolism ; Receptors, Cell Surface/genetics ; Recombinant Fusion Proteins/genetics ; Recombinant Fusion Proteins/metabolism ; S-Adenosylmethionine/metabolism ; Transcobalamins/genetics ; Transcobalamins/metabolism ; Vitamin B 12 Deficiency/genetics ; Vitamin B 12 Deficiency/metabolism ; Vitamin B 12 Deficiency/physiopathology ; Mice
    Chemical Substances RNA, Messenger ; Receptors, Cell Surface ; Recombinant Fusion Proteins ; Transcobalamins ; transcobalamin receptor ; S-Adenosylmethionine (7LP2MPO46S) ; N-methyladenosine (CLE6G00625) ; Prkca protein, mouse (EC 2.7.11.13) ; Protein Kinase C-alpha (EC 2.7.11.13) ; Adenosine (K72T3FS567)
    Language English
    Publishing date 2021-07-29
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2160372-8
    ISSN 1613-4133 ; 1613-4125
    ISSN (online) 1613-4133
    ISSN 1613-4125
    DOI 10.1002/mnfr.202100206
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Lipoate protein ligase B primarily recognizes the C

    Dhembla, Chetna / Yadav, Usha / Kundu, Suman / Sundd, Monica

    The Journal of biological chemistry

    2022  Volume 298, Issue 8, Page(s) 102203

    Abstract: ... of lipoate protein ligase B (LipB) and lipoyl synthase (LipA). LipB takes up the octanoyl chain from C ...

    Abstract Lipoic acid is a sulfur-containing cofactor indispensable for the function of several metabolic enzymes. In microorganisms, lipoic acid can be salvaged from the surroundings by lipoate protein ligase A (LplA), an ATP-dependent enzyme. Alternatively, it can be synthesized by the sequential actions of lipoate protein ligase B (LipB) and lipoyl synthase (LipA). LipB takes up the octanoyl chain from C
    MeSH term(s) Acyl Carrier Protein/metabolism ; Acyltransferases/chemistry ; Acyltransferases/metabolism ; Coenzyme A/metabolism ; Escherichia coli/chemistry ; Escherichia coli/enzymology ; Escherichia coli Proteins/chemistry ; Escherichia coli Proteins/metabolism ; Ligases/metabolism ; Pantetheine/analogs & derivatives ; Thioctic Acid/metabolism
    Chemical Substances Acyl Carrier Protein ; Escherichia coli Proteins ; Pantetheine (496-65-1) ; Thioctic Acid (73Y7P0K73Y) ; Acyltransferases (EC 2.3.-) ; LipB protein, E coli (EC 2.3.1.-) ; Ligases (EC 6.-) ; 4'-phosphopantetheine (NM39WU8OFM) ; Coenzyme A (SAA04E81UX)
    Language English
    Publishing date 2022-06-25
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2997-x
    ISSN 1083-351X ; 0021-9258
    ISSN (online) 1083-351X
    ISSN 0021-9258
    DOI 10.1016/j.jbc.2022.102203
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Human Cyclophilin B Nuclease Activity Revealed via Nucleic Acid-Based Electrochemical Sensors.

    Clark, Vincent / Waters, Kelly / Orsburn, Ben / Bumpus, Namandjé N / Kundu, Nandini / Sczepanski, Jonathan T / Ray, Partha / Arroyo-Currás, Netzahualcóyotl

    Angewandte Chemie (International ed. in English)

    2022  Volume 61, Issue 45, Page(s) e202211292

    Abstract: Human cyclophilin B (CypB) is oversecreted by pancreatic cancer cells, making it a potential ...

    Abstract Human cyclophilin B (CypB) is oversecreted by pancreatic cancer cells, making it a potential biomarker for early-stage disease diagnosis. Our group is motivated to develop aptamer-based assays to measure CypB levels in biofluids. However, human cyclophilins have been postulated to have collateral nuclease activity, which could impede the use of aptamers for CypB detection. To establish if CypB can hydrolyze electrode-bound nucleic acids, we used ultrasensitive electrochemical sensors to measure CypB's hydrolytic activity. Our sensors use ssDNA and dsDNA in the biologically predominant d-DNA form, and in the nuclease resistant l-DNA form. Challenging such sensors with CypB and control proteins, we unequivocally demonstrate that CypB can cleave nucleic acids. To our knowledge, this is the first study to use electrochemical biosensors to reveal the hydrolytic activity of a protein that is not known to be a nuclease. Future development of CypB bioassays will require the use of nuclease-resistant aptamer sequences.
    MeSH term(s) Humans ; Cyclophilins/metabolism ; DNA ; Endonucleases ; Nucleic Acids ; Pancreatic Neoplasms ; Electrochemical Techniques
    Chemical Substances cyclophilin B (137497-17-7) ; Cyclophilins (EC 5.2.1.-) ; DNA (9007-49-2) ; Endonucleases (EC 3.1.-) ; Nucleic Acids
    Language English
    Publishing date 2022-10-06
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, N.I.H., Extramural
    ZDB-ID 2011836-3
    ISSN 1521-3773 ; 1433-7851
    ISSN (online) 1521-3773
    ISSN 1433-7851
    DOI 10.1002/anie.202211292
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma.

    Alkhaldi, Hanan / Reinhardt, Alec / Barnett, Melissa / Kundu, Suprateek / Hosing, Chitra / Ramdial, Jeremy / Saini, Neeraj / Srour, Samer / Alousi, Amin / Kebriaei, Partow / Popat, Uday / Qazilbash, Muzaffar / Champlin, Richard / Shpall, Elizabeth J / Gulbis, Allison / Shigle, Terri Lynn / Dabaja, Bouthaina / Pinnix, Chelsea / Ahmed, Sairah /
    Steiner, Raphael / Andersson, Borje S / Nieto, Yago

    Transplantation and cellular therapy

    2023  Volume 29, Issue 11, Page(s) 690–694

    Abstract: Primary mediastinal large B-cell lymphoma (PMBCL) is an uncommon, aggressive type ...

    Abstract Primary mediastinal large B-cell lymphoma (PMBCL) is an uncommon, aggressive type of non-Hodgkin lymphoma. Rituximab-containing chemoimmunotherapy with or without radiation therapy (RT) is standard first-line treatment. Relapsed or refractory (R/R) disease has long been treated with salvage chemotherapy followed by high-dose chemotherapy (HDC), with autologous stem cell transplantation (ASCT) in appropriate patients. We retrospectively analyzed all patients with R/R PMBCL treated with HDC/ASCT at our center between January 2000 and August 2022. The 60 study patients received either rituximab-BEAM (n = 37) or rituximab-gemcitabine/busulfan/melphalan (R-GemBuMel) with or without vorinostat (n = 23), followed by ASCT. Forty-six patients received mediastinal RT, either as prior consolidation of frontline therapy or following ASCT. At median follow-up of 6 years (range, .3 to 21 years), the 5-year progression-free survival (PFS) and overall survival (OS) rates of the whole group were 58% and 77%, respectively, for the entire cohort, 51% and 65% for the R-BEAM recipients, and 69% and 82% for R-vorinostat/GemBuMel recipients. Multivariable analyses showed that a negative positron emission tomography scan at ASCT (hazard ratio [HR], .28) and involvement of only 1 organ (HR, .33) were independently associated with improved PFS. In addition, receipt of R-vorinostat/GemBuMel (HR, .23) was an independent favorable predictor of OS. Our data indicate that HDC/ASCT is effective in R/R PMBCL, with improved outcomes in patients receiving R-vorinostat/GemBuMel.
    MeSH term(s) Adult ; Humans ; Hematopoietic Stem Cell Transplantation/methods ; Rituximab/therapeutic use ; Vorinostat ; Retrospective Studies ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Melphalan/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Transplantation, Autologous ; Lymphoma, Large B-Cell, Diffuse/diagnostic imaging ; Lymphoma, Large B-Cell, Diffuse/drug therapy ; Thymus Neoplasms/drug therapy ; Thymus Neoplasms/etiology
    Chemical Substances Rituximab (4F4X42SYQ6) ; Vorinostat (58IFB293JI) ; Melphalan (Q41OR9510P)
    Language English
    Publishing date 2023-08-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3062231-1
    ISSN 2666-6367
    ISSN (online) 2666-6367
    DOI 10.1016/j.jtct.2023.08.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Response to: Letter from P. Gillard and B. Benninghoff.

    Rathi, Niraj / Desai, Sajjad / Kawade, Anand / Venkatramanan, Padmasani / Kundu, Ritabrata / Lalwani, Sanjay K / Dubey, A P / Venkateswara Rao, J / Narayanappa, D / Ghildiyal, Radha / Gogtay, Nithya J / Venugopal, P / Palkar, Sonali / Munshi, Renuka / Kang, Gagandeep / Babji, Sudhir / Bavdekar, Ashish / Juvekar, Sanjay / Ganguly, Nupur /
    Niyogi, Prabal / Uttam, Kheya Ghosh / Rajani, H S / Kondekar, Alpana / Kumbhar, Dipti / Mohanlal, Smilu / Agarwal, Mukesh C / Shetty, Parvan / Antony, Kalpana / Gunale, Bhagwat / Dharmadhikari, Abhijeet / Tang, Yuxiao / Kulkarni, Prasad S / Flores, Jorge

    Vaccine

    2019  Volume 37, Issue 23, Page(s) 2991–2992

    MeSH term(s) Animals ; Asian Continental Ancestry Group ; Cattle ; Humans ; Infant ; Research Design ; Rotavirus ; Vaccination
    Language English
    Publishing date 2019-05-09
    Publishing country Netherlands
    Document type Letter ; Comment
    ZDB-ID 605674-x
    ISSN 1873-2518 ; 0264-410X
    ISSN (online) 1873-2518
    ISSN 0264-410X
    DOI 10.1016/j.vaccine.2019.04.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Management strategies and survival in cutaneous B-cell lymphoma: A population based study.

    Lauck, Kyle / Ahmad, Areebah S / Nguyen, Quoc-Bao D / Yang, Zixi / Kundu, Suprateek / Huen, Auris O

    JAAD international

    2023  Volume 13, Page(s) 28–29

    Language English
    Publishing date 2023-07-12
    Publishing country United States
    Document type Journal Article
    ISSN 2666-3287
    ISSN (online) 2666-3287
    DOI 10.1016/j.jdin.2023.06.015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Discovery of pharmacological agents for triple-negative breast cancer (TNBC): molecular docking and molecular dynamic simulation studies on 5-lipoxygenase (5-LOX) and nuclear factor kappa B (NF-κB).

    Kundu, Sudipto / N, Swathi / T, Durai Ananda Kumar

    Journal of biomolecular structure & dynamics

    2023  , Page(s) 1–14

    Abstract: ... factor kappa B (NF-κB) activation induces cell survival in breast cancer through stimulation ... of angiogenesis. Therefore, inhibiting NF-B signalling can stop the growth of tumours. In light of these facts ... A102, A240, A86 and A58 were identified. The higher NF-B inhibiting potential of A169 was discovered ...

    Abstract Global burden of breast cancer is expected to cross 26 million new cases by 2030. The term 'triple negative breast cancer' (TNBC) refers to lack of expression of hormone receptors (ER, PR and HER2). 5-Lipoxygenase (5-LOX) inhibition promotes breast cancer apoptosis, ferroptosis and inhibits metastases. Nuclear factor kappa B (NF-κB) activation induces cell survival in breast cancer through stimulation of angiogenesis. Therefore, inhibiting NF-B signalling can stop the growth of tumours. In light of these facts, an attempt is made to investigate binding characteristics of LOX inhibitors against 5-LOX (PDB-IDs 3V99 and 6N2W) and NF-κB (PDB-IDs 4KIK and 3DO7) through molecular docking, MM-GBSA calculation, molecular dynamic simulations (MDSs) and drug-likeness analysis. The eight lead molecules A169, A156, A162, A154, A102, A240, A86 and A58 were identified. The higher NF-B inhibiting potential of A169 was discovered through the sequential HTVS, SP docking and XP docking study. The hydrophobic interaction of Leu607, Phe610, Gln557 and Asn554 with 3V99 and Cys99, Glu97 and Arg20 of 4KIK is crucial for the inhibition. The LE, LLE and FQ values of A169 suggest their optimal binding with the target. This study strongly suggests the LOX and NF-κB inhibitory potential of A169, further lead optimisation and biological validation requires for the confirmations.Communicated by Ramaswamy H. Sarma.
    Language English
    Publishing date 2023-09-15
    Publishing country England
    Document type Journal Article
    ZDB-ID 49157-3
    ISSN 1538-0254 ; 0739-1102
    ISSN (online) 1538-0254
    ISSN 0739-1102
    DOI 10.1080/07391102.2023.2250449
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Effectiveness of COVID-19 Vaccines against Delta Variant (B.1.617.2): A Meta-Analysis.

    Mahumud, Rashidul Alam / Ali, Mohammad Afshar / Kundu, Satyajit / Rahman, Md Ashfikur / Kamara, Joseph Kihika / Renzaho, Andre M N

    Vaccines

    2022  Volume 10, Issue 2

    Abstract: Objectives: ...

    Abstract Objectives:
    Language English
    Publishing date 2022-02-11
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2703319-3
    ISSN 2076-393X
    ISSN 2076-393X
    DOI 10.3390/vaccines10020277
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Exploration of Benzo[b]carbazole-6,11-diones as anticancer agents: Synthesis and studies of hTopoIIα inhibition and apoptotic effects.

    Sisodiya, Shailendra / Paul, Subarno / Chaudhary, Hiteshkumar / Grewal, Preeti / Kumar, Gulshan / Daniel, Divine P / Das, Biswajit / Nayak, Deepika / Guchhait, Sankar K / Kundu, Chanakya N / Banerjee, Uttam C

    Bioorganic & medicinal chemistry letters

    2021  Volume 49, Page(s) 128274

    Abstract: Two series of (hetero)arylamino-naphthoquinones and benzo-fused carbazolequinones were considered for study with the rationale that related structural motifs are present in numerous drugs, clinical trial agents, natural products and hTopoIIα inhibitors. ... ...

    Abstract Two series of (hetero)arylamino-naphthoquinones and benzo-fused carbazolequinones were considered for study with the rationale that related structural motifs are present in numerous drugs, clinical trial agents, natural products and hTopoIIα inhibitors. Total 42 compounds were synthesized by reactions including dehydrogenative CN and Pd-catalyzed CC bond forming transformations. These compounds were screened against numerous cancer cells including highly metastatic one (MCF-7, MDA-MB-231, H-357 and HEK293T), and normal cells (MCF 10A). Some of the active compounds were evaluated for clonogenic cell survival and apoptotic effects in cancer cells (DAPI nuclear staining, Comet assay, Annexin-V-FITC/PI dual staining, flow cytometry, and western blot analysis with relevant proteins). All compounds were tested for hTopoIIα inhibitory activity. The investigated series compounds showed important properties like significant apoptotic antiproliferation in cancer cells with cell cycle arrest at S-phase and downregulation of NF- κβ signaling cascade, relatively less cytotoxicity to normal cells, and hTopoIIα inhibition with more efficiency compared to an anticancer drug etoposide.
    MeSH term(s) Antineoplastic Agents/chemical synthesis ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/toxicity ; Apoptosis/drug effects ; Carbazoles/chemical synthesis ; Carbazoles/pharmacology ; Carbazoles/toxicity ; Cell Line, Tumor ; Cell Proliferation/drug effects ; DNA Topoisomerases, Type II/metabolism ; Drug Screening Assays, Antitumor ; HEK293 Cells ; Humans ; Naphthoquinones/chemical synthesis ; Naphthoquinones/pharmacology ; Naphthoquinones/toxicity ; Poly-ADP-Ribose Binding Proteins/metabolism ; S Phase Cell Cycle Checkpoints/drug effects ; Signal Transduction/drug effects ; Topoisomerase II Inhibitors/chemical synthesis ; Topoisomerase II Inhibitors/pharmacology ; Topoisomerase II Inhibitors/toxicity
    Chemical Substances Antineoplastic Agents ; Carbazoles ; Naphthoquinones ; Poly-ADP-Ribose Binding Proteins ; Topoisomerase II Inhibitors ; DNA Topoisomerases, Type II (EC 5.99.1.3) ; TOP2A protein, human (EC 5.99.1.3)
    Language English
    Publishing date 2021-07-22
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1063195-1
    ISSN 1464-3405 ; 0960-894X
    ISSN (online) 1464-3405
    ISSN 0960-894X
    DOI 10.1016/j.bmcl.2021.128274
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top